Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer

By Petrelli Fausto   Borgonovo Karen   Lonati Veronica   Elia Stefano   Barni Sandro  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 291-294

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM × anti-CD3): a phase I study

By Sebastian Martin   Passlick Bernward   Friccius-Quecke Hilke   Jäger Michael   Lindhofer Horst   Kanniess Frank   Wiewrodt Rainer   Thiel Eckhard   Buhl Roland   Schmittel Alexander  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1637-1644

Springer Publishing Company

Access to resources Recommend Favorite

Peritoneal carcinomatosis from colorectal cancer: treatment options

By Warrier Satish K   Lynch A Craig  

Colorectal Cancer, Vol. 2, Iss. 5, 2013-10 ,pp. : 441-447

Future Medicine

Access to resources Recommend Favorite

Chemotherapy Treatment of Chyloperitoneum and Peritoneal Carcinomatosis Due to Cervical Cancer-Review of Literature

By Keung Y.K.   Whitehead R.P.   Cobos E.  

Gynecologic Oncology, Vol. 61, Iss. 3, 1996-06 ,pp. : 448-450

Academic Press

Access to resources Recommend Favorite

Lung cancer and peritoneal carcinomatosis

By              

Oncology Letters, Vol. 6, Iss. 3, 2013-01 ,pp. : 705-708

Spandidos Publications

Access to resources Recommend Favorite